- Our Doctors
- Dr Mymoona Alzouebi
/content/dam/genesiscare/headshots/uk-doctor-headshots/UK_Consultant_Oncologist_Head_shot_GA_Mymoona_Alzouebi.jpeg
Dr Mymoona Alzouebi
Dr Mymoona Alzouebi
Mymoona
Alzouebi
MBChB, MRCP, DTMH, MSc Oncology, FRCR, Consultant Clinical Oncologist
Languages spoken
English
Expert in
Prostate, kidney and bladder cancer.
Overview
Centres
Nottingham
Nottingham
The Park Centre Oncology, Sherwood Lodge Drive, Burntstump Country Park, Nottingham, Nottinghamshire, NG5 8RX, England, UK
53.050498950912186, -1.1434615981524467
/uk/our-centres/nottingham
Nottinghamshire
Specializes in
Bladder cancer
Renal cancer
Ureter cancer
Treatments
Dr Alzouebi is Consultant Clinical Oncologist specialising in the treatment of prostate, kidney and bladder cancer. She’s an expert in cancer care using the most advanced and up to date treatment modalities. She’s actively involved in clinical trials and research and is the local principal investigator on several national clinical trials.
Dr Alzouebi qualified from the University of Sheffield in 2004. After completing general medical training in the Yorkshire Deanery she undertook the Clinical Oncology training programme at Weston Park Hospital in Sheffield and completed a Masters in Oncology in 2010 and obtained FRCR qualification in 2012.
Career positions
Current position(s)
- Weston Park Hospital, Sheffield
Thornbury, Sheffield
Education
Universities
- University of Sheffield (2004)
- Clinical Oncology training programme, Weston Park Hospital in Sheffield
- Masters in Oncology in 2010
- FRCR qualification in 2012.
Expertise and interests
Interests
- RapidArc
- MRI Linac credentialed for prostate cancer SABR
Accomplishments
Publications
- M Alzouebi, R Jones. Outcomes of 10 years prescribing practice for first line metastatic kidney cancer. NCRI 2018
- M Alzouebi, JR Goepel, JM Horsman and BW Hancock. Primary thyroid lymphoma: The 40 year experience of a UK lymphoma treatment centre. Int J Oncol 40: 2075-2080, 2012
- M Alzouebi, S Pledge and J Martin. Are outcomes of adjuvant vaginal vault brachytherapy in endometrial cancer related to the way it is delivered? Journal of Radiotherapy in Practice. FirstView Article : pp 1-14 Published online: 12 December 2011
- M Alzouebi, P Fisher, PJ Woll, MQ Hatton, BH Foran. Audit of adjuvant vinorelbine and cisplatin for patients with resected NSCLC. Lung Cancer 2010;67:S1
- M Alzouebi, P Sarrigiannis, M Hadjivassiolou. Acute Polyradiculopathy with renal failure; mind the anion gap – Journal of Neurology, Neurophysiology and Psychiatry Psychiatry 2008;79:842-844
Professional association
- General Medical Council
- Royal College of Radiologists
- British Uro-Oncology Group